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2. Materials and methods 
1. Introduction 
We have previously reported that the aspartate 
aminotransferases (EC 2.6.1 .l) from pig heart cyto- 
plasm and mitochondria are homologous proteins [ 11. 
This conclusion was based on limited and fragmentary 
sequence data but similar conclusions have been 
reached independently [2,3]. We present here a 
structure for the mitochondrial aspartate aminotrans- 
ferase, complete apart from the assignment of some 
acid and amide side chains, and compare this 
structure with that of the cytoplasmic isozyme [4,5]. 
It seems to be of interest to report the structure in its 
present form because there is still no other case where 
the structural relationships between a pair of cyto- 
plasmic and mitochondrial isozymes have been 
established. In addition, work is now in progress on 
the crystal structure of the mitochondrial aspartate 
aminotransferase from chicken heart [6]. Published 
data on the primary structure of the chicken heart 
enzyme are limited to an N-terminal sequence of 
40 residues [7]. In this region, the sequences of the 
pig and chicken heart enzymes are very similar; 
indeed, it has been claimed on the basis of immuno- 
chemical studies that the sequence identity of the 
two enzymes may be as high as 80% [8]. Hence it 
seems likely that the results presented here will be of 
assistance both in the primary structure analysis and 
crystallographic analysis of the chicken heart enzyme. 
Mitochondrial aspartate aminotransferase was 
purified by the method previously described [9]. 
Digestions of chemically modified protein were carried 
out as follows: 
(i) The aminoethylated protein was digested both with 
trypsin and with the lysine specific protease from 
Armillaria mellea. 
(ii) The sodium borohydride-reduced and carboxy- 
methylated protein (iodo-[14C]acetic acid) was 
digested with chymotrypsin, with thermolysin and 
with pepsin. 
(iii) The protein with lysine residues trifluoroacetylated 
and cysteine residues aminoethylated was digested 
with the A. mellea protease. 
Details of the digestion procedures and the methods 
used for subsequent isolation of peptides have been 
described previously [4,10-121. Sequence analysis was 
carried out by using the dansyl Edman method as 
described by Hartley [ 131. C-terminal sequences were 
frequently determined or confirmed by digestion with 
carboxypeptidases. Some large fragments were sub- 
digested with appropriate proteases and the product 
peptides isolated and sequenced. Amino acid sequences 
were usually supported by quantitative amino acid 
analysis; in later stages of the work sequences of pep- 
tides derived from well known regions of the structure 
could be deduced from amino acid compositions alone. 
Assignments of side-chain amide groups were made 
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either by amino acid analysis after digestion of pep- 
tides with exopeptidases or by measurements of 
mobility on electrophoresis at pH 6.5 [ 141. 
3. Results and discussion 
Figure 1 compares the amino acid sequence of 
cytoplasmic aspartate aminotransferase from pig 
heart [4] with that of the mitochondrial isozyme. 
The major part of the latter structure was determined 
from peptides obtained by digestion with trypsin, 
chymotrypsin, thermolysin and pepsin. In some of 
these digests, particularly that with pepsin, several 
peptides were found originating from the same 
regions of the structure due to partial cleavage of 
susceptible bonds. Generally only one peptide 
from such regions is shown in fig.1. Recently we 
have attempted more restricted digestion procedures 
using the A. mellea protease and cyanogen bromide. 
Results from this work are still incomplete but those 
that provide essential information have been included 
here. 
9 residues less than in the cytoplasmic form. The 
native enzyme is a dimer of these chains [9]. For 
maximum homology deletions of two residues at both 
the N-terminal and the C-terminal ends of the mito- 
chondrial isozyme must be assumed. Other deletions 
are then at or around positions 64,125, 126,154 and 
407. The degree of homology between the two 
isozymes cannot be finally assesed ue to incomplete 
assignment of amide side chains. If the assumption 
is made that the state of amidation is the same as that 
in the cytoplasmic isozyme where Asx is coincident 
with Asp or Asn (and similarly with Glx) then 194 
residues occur in identical positions in the two 
isozymes (i.e. approx. 48% identity). This is clearly, 
however, an upper limit since 26 acid/amide side 
chains remain unassigned. 
There are some points of uncertainty in the 
structure given and these require comment. In what 
follows, the numbering system used is that of the 
cytoplasmic isozyme. The overlap at positions 
122-l 23 cannot by itself be considered sufficient 
to locate the small tryptic peptide Phe-Phe-Lys 
with certainty. However, this peptide was also found 
in a subdigest with trypsin of a cyanogen bromide 
fragment originating from asparagine-34 to methionine- 
152; combined with the other evidence in fig.1 this 
provides strong confirmation of the sequence given. 
The tryptic peptide at positions 132-137 was assumed 
to have arisen from a chymotryptic type cleavage after 
tryptophan but a formal overlap between residues 13 1 
and 132 is lacking; we have no evidence for the 
existence of a further basic residue in this region. 
The homology between the two structures varies 
greatly in different regions. For example, it is very 
low at the N-terminus (5 identities in the first 30 
residues), but this is followed by a region of high 
similarity (residues 32-41). This latter region 
contains a tyrosine residue (40) that is thought to 
be near the active site in the cytoplasmic isozyme if 
not directly involved in the enzyme action [ 151. 
Similarly, the cofactor binding sites (lysine-258 in 
both cases [ 1,3,16]) are in a region of high 
similarity. It will be of interest to examine the roles 
of other highly conserved regions when the three 
dimensional structure of the homologous chicken 
heart mitochondrial isozyme is available. 
Acknowledgements 
Financial support from the Science Research 
Council (G.J.H.) and the British Council (H.M.A.F.) 
is gratefully acknowledged. 
The two other overlaps that are lacking are those 
between residues 380-381 and 386-387; the position- 
ing of the peptide covering residues 381-386 has, 
therefore, been done solely on the basis of homology. 
Given that the rest of the structure is established, this 
positioning seems entirely reasonable. 
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